… , we feel oral anticoagulation with Warfarin in patients with cancer is both safe and effective.
The optimal choice of either inferior vena cava filter placement or oral anticoagulation for …

… efficacy and safety of … the efficacy and safety of rivaroxaban and warfarin between elderly
and young participants in the RCT; however, our aim is to solely look at the efficacy and safety …

… oral anticoagulation prior to and immediately after the procedure. The recently published
COMPARE randomized trial [4] has shown the superiority of uninterrupted oral anticoagulation …

… Use of direct oral anticoagulants (DOACs) in PVT has been met with concern because of
the lack of data. We conducted a retrospective study to investigate the efficacy and safety of …

… This study sought to investigate the relative efficacy and safety of non-vitamin K oral
anticoagulants (NOACs) for the treatment of venous thromboembolism (VTE) in cancer patients. …

… comparisons of the efficacy and safety of the various new oral anticoagulants cannot be …
efficacy of rivaroxaban over enoxaparin in the RECORD studies, and the superior efficacy of …

… Though this study provided insight on the efficacy and safety of rivaroxaban, the patient
numbers were small and direct comparisons with its phase III trial were not possible. …

… of the safety outcomes signifies an overall reduced risk of bleeding in oral anticoagulants, …
In general, an obesity paradox can be interpreted as our results indicate that the efficacy …

… This study was designed to compare efficacy and safety among novel oral anticoagulants
(NOACs), which have not been directly compared in randomized control trials to date. …

… Individual studies have demonstrated comparable efficacy to that of vitamin K antagonists (…
favorable safety profile . We performed a meta‐analysis to determine the efficacy and safety of …